Literature DB >> 19936600

One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008.

Masaru Miyazaki1, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Masayuki Otuka, Atushi Kato, Hideyuki Yoshitomi, Katsunori Furukawa, Dan Takeuchi, Tsukasa Takayashiki, Kousuke Suda, Shigetugu Takano.   

Abstract

Many authors at high-volume centers all over the world have reported improved outcomes of hilar cholangiocarcinoma by several aggressive surgical approaches such as extended hepatic resection, combined vascular resection, and hepatopancreaticoduodenectomy in recent years. There has been great progress in the surgical treatment of hilar cholangiocarcinoma with these previous efforts by aggressive hepatobiliary surgeons. In particular, surgical techniques, diagnostic modalities, and perioperative management have been remarkably improved as compared with before. Herein we report the surgical outcome for both hilar cholangiocarcinoma of Bismuth types II, III, and IV and intrahepatic cholangiocarcinoma involving the hepatic duct confluence during the recent 8-year period between 2001 and 2008 at our institution, the Department of General Surgery at Chiba University. From our recent experienced results, it can be concluded that the surgical strategy for hilar cholangiocarcinoma has been improved remarkably, and major surgical hepatectomy can be done with relative safety, and these aggressive surgical approaches, including combined vascular resection, may be warranted for the surgical treatment of hilar cholangiocarcinoma. However, the adoption of new innovative therapeutic approaches might be required for further improvement of surgical outcome of hilar cholangiocarcinoma.

Entities:  

Mesh:

Year:  2009        PMID: 19936600     DOI: 10.1007/s00534-009-0207-2

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  26 in total

Review 1.  [Resection of Klatskin tumors].

Authors:  D Seehofer; C Kamphues; P Neuhaus
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

2.  Isolated caudate lobectomy with pancreatoduodenectomy for a bile duct cancer.

Authors:  Tsuyoshi Sano; Yasuhiro Shimizu; Yoshiki Senda; Koji Komori; Seiji Ito; Tetsuya Abe; Taira Kinoshita; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2013-09-13       Impact factor: 3.445

Review 3.  Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma.

Authors:  Saleh Abbas; Charbel Sandroussi
Journal:  HPB (Oxford)       Date:  2013-01-08       Impact factor: 3.647

4.  Unresectable hilar cholangiocarcinoma treated with chemoradiotherapy: a 9-year survival case.

Authors:  Takeshi Sakata; Takahiro Yoshikawa; Takeo Nomi; Yasuko Matsuo; Naoki Kamitani; Daisuke Hokuto; Masayuki Sho
Journal:  Int Cancer Conf J       Date:  2020-09-19

5.  Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution.

Authors:  Ryota Higuchi; Takehiro Ota; Takehisa Yazawa; Hideki Kajiyama; Tatsuo Araida; Toru Furukawa; Tatsuya Yoshikawa; Ken Takasaki; Masakazu Yamamoto
Journal:  Surg Today       Date:  2015-02-05       Impact factor: 2.549

6.  Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma.

Authors:  Ryusei Matsuyama; Daisuke Morioka; Ryutaro Mori; Yasuhiro Yabushita; Seigo Hiratani; Yohei Ota; Takafumi Kumamoto; Itaru Endo
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

Review 7.  Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.

Authors:  Masato Nagino
Journal:  J Gastroenterol       Date:  2012-07-31       Impact factor: 7.527

8.  Impact of Biliary Drainage on Multidetector-Row Computed Tomography on R0 Resection of Perihilar Cholangiocarcinoma.

Authors:  Isamu Hosokawa; Hiroaki Shimizu; Hideyuki Yoshitomi; Katsunori Furukawa; Tsukasa Takayashiki; Masaru Miyazaki; Masayuki Ohtsuka
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

9.  Surgical management trends for cholangiocarcinoma in the USA 1998-2009.

Authors:  Jamie E Anderson; Alan W Hemming; David C Chang; Mark A Talamini; Kristin L Mekeel
Journal:  J Gastrointest Surg       Date:  2012-07-31       Impact factor: 3.452

Review 10.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.